CYT-0851

· Cyteir Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CYT-0851, covering 2024-12-24 to 2024-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors [Phase 1, Phase 2]